Viw Magazine

Men's Weekly

.

Grand Pharma’s Innovative Product for Liver Tumors, Y-90, Is Commercialized in Mainland China, Empowering "Nuclear Power" to The Company’s Performance

  • Written by Viw Magazine
HONG KONG SAR - Media OutReach - 20 June 2022 - On 19 June, the technology innovation pharmaceutical company, Grand Pharmaceutical Group Limited (stock code: 0512.HK)’s global innovative product, SIR-Spheres® Y-90 microsphere injection for the treatment of liver malignant tumors, was officially commercialized in Mainland China.

Read more

LifeStyle

All Aboard! River Cruising No Longer Just For Rich Boomers

If you live on the canals of the Gold Coast, the mighty Yarra or even along the estuaries of Sydney...

Life With Clear Aligners: 10 Small Changes That Make a Big Difference

Image by tonodiaz on Freepik Clear aligners have transformed orthodontics, offering a nearly invis...

Choosing the Right Hair Loss Treatment for Your Needs

Millions of people experience hair loss globally, and it can be a major cause of emotional discomf...

Why Choose Private Tutoring in Sydney?

In today’s competitive academic environment, personalised support can make a world of difference...